Free Trial

Cott Q2 2023 Earnings Report

C$13.15 +0.09 (+0.69%)
As of 12:11 PM Eastern

Cott EPS Results

Actual EPS
C$0.29
Consensus EPS
C$0.26
Beat/Miss
Beat by +C$0.03
One Year Ago EPS
N/A

Cott Revenue Results

Actual Revenue
$796.96 million
Expected Revenue
$791.01 million
Beat/Miss
Beat by +$5.95 million
YoY Revenue Growth
N/A

Cott Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Cott Earnings Headlines

No headlines for this company have been tracked by MarketBeat.com
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cott? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cott and other key companies, straight to your email.

About Cott

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

View Cott Profile

More Earnings Resources from MarketBeat